Page last updated: 2024-11-06

lysergic acid diethylamide and Carcinoma, Ehrlich Tumor

lysergic acid diethylamide has been researched along with Carcinoma, Ehrlich Tumor in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ueki, H1
Tsunemi, S1
Kubota, Y1
Shohat, B1
Joshua, H1

Other Studies

2 other studies available for lysergic acid diethylamide and Carcinoma, Ehrlich Tumor

ArticleYear
Vascular permeability-increasing action of hypoalbuminemic substance from Ehrlich ascites carcinoma cells.
    Gan, 1975, Volume: 66, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Carcinoma, Ehrlich Tumor; Depression, Che

1975
Isolation of a pharmacologically active principle from Ehrlich carcinoma tumor cells.
    Experientia, 1971, Volume: 27, Issue:8

    Topics: Animals; Atropine; Blood Pressure; Carcinoma, Ehrlich Tumor; Female; Ileum; In Vitro Techniques; Lys

1971